Presentations and outcomes of neurosarcoidosis: A study of 54 cases

QJM: An International Journal of Medicine

Volumn 102, Issue 7, 2009, Pages 449-460

  Pawate, Siddharama ^a   Moses, H ^a   Sriram, S ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; AZATHIOPRINE; DIPEPTIDYL CARBOXYPEPTIDASE; GLUCOSE; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OLIGOCLONAL BAND; PREDNISONE; RITUXIMAB; STEROID;

ADOLESCENT; ADULT; AGED; ARTICLE; ATAXIA; BRAIN BIOPSY; BRAIN DISEASE; CEREBROSPINAL FLUID ANALYSIS; CHILD; COCHLEA PROSTHESIS; CRANIAL NEUROPATHY; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG WITHDRAWAL; FACIAL NERVE PARALYSIS; FEMALE; HEADACHE; HEARING LOSS; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; HYPOPITUITARISM; IMAGE ENHANCEMENT; IMMUNOSUPPRESSIVE TREATMENT; LONG TERM CARE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE LESION; OUTCOME ASSESSMENT; PERIPHERAL NEUROPATHY; PLEOCYTOSIS; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; SARCOIDOSIS; SCHOOL CHILD; SEIZURE; SENSITIVITY AND SPECIFICITY; SPINAL CORD DISEASE; THORAX RADIOGRAPHY; VERTIGO;

EID: 67650508096     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcp042     Document Type: Article

References (26)

1. Lannuzzi M, Rybicki B, Tierstein A. Sarcoidosis. New Engl J Med 2007; 357:2153-65.
2. Rybicki BA, Iannuzzi MC. Epidemiology of sarcoidosis: Recent advances and future prospects. Semin Respir Crit Care Med 2007; 28 22-35.
3. Lynch J, Ma Y, Koss M, White E. Pulmonary sarcoidosis. Semin Respir Crit Care Med 2007; 28:53-74.
4. Judson M. Extrapulmonary sarcoidosis. Semin Respir Crit Care Med 2007; 28:83-101.
5. Joseph FG, Scolding NJ. Sarcoidosis of the nervous system. Pract Neurol 2007; 7:234-44.
6. Stern BJ. Neurological complications of sarcoidosis. Curr Opin Neurol 2004; 17:311-6.
7. Hoitsma E, Faber CG, Drent M, Sharma OP. Neurosarcoidosis: A clinical dilemma. Lancet Neurol 2004; 3:397-407.
8. Chapelon C, Ziza JM, Piette JC, Levy Y, Raguin G, Wechsler B, et al Neurosarcoidosis: Signs, course and treatment in 35 confirmed cases. Medicine 1990; 69:261-76.
9. Zajicek JP, Scolding NJ, Foster O, Rovaris M, Evanson J, Moseley IF, et al. Central nervous system sarcoidosis-diagnosis and management. QJM 1999; 92:103-17.
10. Scott TF, Yandora K, Valeri A, Chieffe C, Schramke C. Aggressive therapy for neurosarcoidosis: Long-term follow-up of 48 treated patients. Arch Neurol 2007; 64:691-6.
11. Marangoni S, Argentiero V, Tavolato B. Neurosarcoidosis. Clinical description of 7 cases with a proposal for a new diagnostic strategy. J Neurol 2006; 253:488-95.
12. Spencer TS, Campellone JV, Maldonado I, Huang N, Usmani Q, Reginato AJ. Clinical and magnetic resonance imaging manifestations of neurosarcoidosis. Semin Arthritis Rheum 2005; 34:649-61.
13. Kellinghaus C, Schilling M, Ludemann P. Neurosarcoidosis: Clinical experience and diagnostic pitfalls. Eur Neurol 2004; 51:84-8.
14. Stern BJ, Krumholz A, Johns C, Scott P, Nissim J. Sarcoidosis and its neurological manifestations. Arch Neurol 1985; 42:909-17.
15. Lury KM, Smith JK, Matheus MG, Castillo M. Neurosarcoidosis - review of imaging findings. Semin Roentgenol 2004; 39:495-504.
16. Fels C, Riegel A, Javaheripour-Otto K, Obenauer S. Neurosarcoidosis: findings in MRI. Clin Imaging 2004; 28:166-9.
17. Smith JK, Matheus MG, Castillo M. Imaging manifestations of neurosarcoidosis. AJR Am J Roentgenol 2004; 182:289-95.
18. Nowak DA, Widenka DC. Neurosarcoidosis: A review of its intracranial manifestation. J Neurol 2001; 248:363-72.
19. Salazar A, Mana J, Albareda JM, Badrinas F, Fernandez-Nogues F. Neurosarcoidosis: Presentation of 14 cases. Med Clin 1993; 100 292-5.
20. Schweisfurth H, Schioberg-Schiegnitz S, Kuhn W, Parusel B. Angiotensin I converting enzyme in cerebrospinal fluid of patients with neurological diseases. Klin Wochenschr 1987; 65:955-8.
21. Oksanen V, Fyhrquist F, Somer H, Gronhagen-Riska C. Angiotensin converting enzyme in cerebrospinal fluid: A new assay. Neurology 1985; 35:1220-3.
22. Jones DB, Mitchell D, Horn DB, Edwards CR. Cerebrospinal fluid angiotensin converting enzyme levels in the diagnosis of neurosarcoidosis. Scott Med J 1991; 36:144-5.
23. Zajicek JP. Neurosarcoidosis. Curr Opin Neurol 2000; 13 323-5.
24. Patel AV, Stickler DE, Tyor WR. Neurosarcoidosis. Curr Treat Options Neurol 2007; 9:161-8.
25. Santos E, Shaunak S, Renowden SA, Scolding NJ. Treatment of refractory neurosarcoidosis with infliximab. J Neurol Neurosurg Psychiatry 2008 Oct 31 [Epub ahead of print].
26. Moravan M, Segal BM. Treatment of CNS sarcoidosis with infliximab and mycophenolate mofetil. Neurology 2009; 72:337-40.